Company Overview
Snapshot
Founded in March 2006 by Avi Lazar, PulmOne operates with 51–200 employees. The company has raised $13.71M across 5 funding rounds from 2 investors. In December 2021, Alpha LTI led a convertible debt funding round.
Business overview
PulmOne develops patient-friendly, budget-conscious devices for accurate clinical decision-making in diagnosing, treating, and monitoring respiratory diseases. Its core product, the MiniBox, is a desktop system for measuring lung volume and spirometry without relying on a plethysmograph or external gas source. The MiniBox+ extends this functionality with a diffusing capacity (DLCO) module, offering a complete solution. The company serves the healthcare industry, including hospitals, clinics, and healthcare providers, operating within the Health Tech & Life Sciences sector, specifically in Medical Devices, Medical Monitors, and Diagnostics Devices.
Strategic signal
In February 2022, PulmOne was highlighted for its portable lung tests, which help patients breathe easier. This indicates a market validation for its innovative approach to pulmonary function testing, suggesting a positive trajectory for adoption and impact in respiratory care.
Log in to access full profile ›Company Intelligence Q&A
- What is PulmOne's primary product?
- PulmOne's primary product is the MiniBox, a desktop device for measuring lung volume and spirometry. The MiniBox+ offers an enhanced version with a diffusing capacity (DLCO) module for a complete pulmonary function testing solution.
- When was PulmOne founded and by whom?
- PulmOne was founded in March 2006 by Avi Lazar.
- What significant product enhancement did PulmOne announce in late 2019?
- In November 2019, PulmOne announced that it was offering FeNO by NIOX® with its MiniBox+™ Complete Pulmonary Function Testing System, expanding its diagnostic capabilities.
- Which investors participated in PulmOne's December 2021 funding round?
- This round was a Convertible Debt funding type.
- What regulatory clearances has PulmOne received for its products?
- PulmOne has received FDA 510k clearance and a CE mark for its first product, enabling sales in several locations.